Apoptosis and angiogenesis: An evolving mechanism for fibrosis

FASEB Journal

Volumn 27, Issue 10, 2013, Pages 3893-3901

  Johnson, Ariel ^a   Di Pietro, Luisa Ann ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Allograft vasculopathy; Liver; Lung; Scar formation; Wound healing

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CARBON TETRACHLORIDE; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; DEATH RECEPTOR; DNA FRAGMENT; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA CONVERTING ENZYME; MATRIX METALLOPROTEINASE; PROCASPASE 8; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; APOPTOSIS; CARDIAC ALLOGRAFT VASCULOPATHY; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CELL TYPE; COLLAGEN SYNTHESIS; DNA FRAGMENTATION; EFFEROCYTOSIS; ENDOCYTOSIS; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; FIBROSIS; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC SCAR; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LIVER FIBROSIS; LUNG ALVEOLUS CELL; LUNG FIBROSIS; MACROPHAGE; NONHUMAN; PARACRINE SIGNALING; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REDUCTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STELLATE CELL; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; WOUND HEALING; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; FIBROSIS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84885114825     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-214189     Document Type: Review

References (80)

1. World Health Organization (2008) The Global Burden of Disease: 2004 Update. World Health Organization, Geneva, Switzerland.
2. Chen, C, and Raghunath, M. (2009) Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art. Fibrogenesis Tissue Repair 2, 7
3. Cohen, G. (1997) Caspases the executioner of apoptosis. Biochem. J. 326, 1-16
4. Rai, N. K. (2005) Apoptosis: a basic physiologic process in wound healing. Int. J. Low. Extrem. Wounds 4, 138-144
5. Chen, C. C., and Lau, L. F. (2010) Deadly liaisons: fatal attraction between CCN matricellular proteins and the tumor necrosis factor family of cytokines. J. Cell Commun. Signal. 4, 63-69
6. Kisseleva, T., and Brenner, D. A. (2008) Mechanisms of fibrogenesis. Exp. Biol. Med. 233, 109-122
7. Khanna, S., Biswas, S., Shang, Y., Collard, E., Kauh, C., Bhasker, V., Gordillo, G. M., Sen, C. K., and Roy, S. (2010) Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 5, e9539
8. Stout, R, Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., and Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349
9. Mathai, S. K., Gulati, M., Peng, X., Russell, T. R, Shaw, A. C., Murray, L. A., Siner, J. M., Antin-Ozerkis, D. E., Montgomery, R. R, Reilkoff, R. A., Bucala, R. J., and Herzog, E. L. (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab. Invest. 90, 812-823
10. Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Peng, X., Gulati, M., Homer, R. J., Russell, T., Van Rooijen, N., Elias, J. A., Hogaboam, C. M., and Herzog, E. L. (2011) TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. Int. J. Biochem. Cell Biol. 43, 154-162
11. Horowitz, J., Cui, Z., Moore, T. A, Meier, T. R, Reddy, R. C., Toews, G. B., and Thannickal, V. J. (2006) Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L415-L425
12. Wynes, M. W., Frankel, S. K., and Riches, D. W. (2004) IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal. J. Leukoc. Biol. 76, 1019-1027
13. Laplante, P., Sirois, I., Raymond, M. A., Kokta, V., Prat, A., Pshezhetsky, A. V., and Hébert, M. J. (2010) Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis. Cell Death Differ. 17, 291-303
14. Berger, A. C., Feldman, A. L., Gnant, M. F., Kruger, E. A., Hewitt, S., Figg, W. D., Alexander, H. R, and Libutti, S. K (2000) The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. J. Surg. Res. 91, 26-31
15. Cailhier, J. F., Laplante, P., and Hebert, M. J. (2006) Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. Am. J. Transplant 6, 247-253
16. Diao, J. S., Xia, W. S., and Guo, S. Z. (2010) Bevacizumab: a potential agent for prevention and treatment of hypertrophic scar. Burns 36, 1136-1137
17. Havasi, A., and Borkan, S. C. (2011) Apoptosis and acute kidney injury. Kidney Int. 80, 29-40
18. Szpaderska, A. M., Walsh, C. G., Steinberg, M. J., and Di Pietro, L. A. (2005) Distinct patterns of angiogenesis in oral and skin wounds. J. Dent. Res. 84, 309-314
19. Uhal, B. D. (2008) The role of apoptosis in pulmonary fibrosis. Eur. Respir. Rev. 17, 138-144
20. Van der Veer, W., Niessen, F. B., Ferreira, J. A., Zwiers, P. J., Middelkoop, E., and Molema, G. (2011) Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans. Wound Repair Regen. 19, 292-301
21. Wang, L., Scabilloni, J. F., Antonini, J. M., Rojanasakul, Y., and Mercer, R. (2006) Induction of secondary apoptosis, inflammation, and lung fibrosis after intratracheal instillation of apoptotic cells in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L696-L702
22. Wang, R., Alam, G., Zagariya, A., Gidea, C., Lalude, O., Choudhary, G., Oezatalay, D., and Uhal, B. D. (2000) Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo. J. Cell. Physiol. 185, 253-259
23. Wynn, T. A. (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117, 524-529
24. Lai, W. K., and Adams, D. H. (2005) Angiogenesis and chronic inflammation: the potential for novel therapeutic approaches in chronic liver disease. J. Hepatol. 42, 7-11
25. Song, B., Zhang, W., Guo, S., Han, Y., Zhang, L., and Lu, K. (2009) Adenovirus-mediated METH1 gene expression inhibits hypertrophic scarring in a rabbit ear model. Wound Repair Regen. 17, 559-568
26. Wang, X., Zhu, H., Yang, X., Bi, Y, and Cui, S. (2010) Vasohibin attenuates bleomycin induced pulmonary fibrosis via inhibition of angiogenesis in mice. Pathology. 42, 457-462
27. Fraisl, P., Mazzone, M., Schmidt, T., and Carmeliet, P. (2009) Regulation of angiogenesis by oxygen and metabolism. Dev. Cell. 16, 167-179
28. Cheresh, D. A., and Stupack, D. G. (2008) Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 27, 6285-6298
29. Dimmeler, S., and Zeiher, A. M. (2000) Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 87, 434-439
30. Nyberg, P., Xie, L., and Kalluri, R. (2005) Endogenous inhibitors of angiogenesis. Cancer Res. 65, 3967-3979
31. Stoneman, V., and Bennett, M. R. (2009) Role of Fas/Fas-L in vascular cell apoptosis. J. Cardiovasc. Pharmacol. 53, 100-108
32. Dulauroy, S., Di Carlo, S. E., Langa, F., Eberl, G., and Peduto, L. (2012) Lineage tracing and genetic ablation of ADAM12 (+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat. Med. 18, 1262-1270
33. Hartlapp, I., Abe, R., Saeed, RW., Peng, T., Bucala, R, and Metz, C. (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 15, 2215-2224
34. Sarrazy, V., Billet, F., Micallef, L., Coulomb, B., and Desmouliere, A. (2011) Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen. 19(Suppl 1), s10-s15
35. Wolfram, D., Tzankov, A., Pulzl, P., and Piza-Katzer, H. (2009) Hypertrophic scars and keloids-a review of their pathophysiology, risk factors, and therapeutic management. Dermatol. Surg. 35, 171-181
36. Van der Veer, W., Bloemen, M. C, Ulrich, M. M., Molema, G., Van Zuijlen, P. P., and Niessen, F. B. (2009) Potential cellular and molecular causes of hypertrophic scar formation. Burns 35, 15-29
37. Riou, J., Cohen, J. R., Johnson, H., Jr. (1992) Factors influencing wound dehiscence. Am. J. Surg. 163, 324-330
38. Greenhalgh, D. (1998) The role of apoptosis in wound healing. Int. J. Biochem. Cell Biol. 30, 1019-1030
39. Desmoulire, A., Redard, M., Darby, I., and Gabbiani, G. (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146, 56-66
40. Benjamin, L. (2000) The controls of microvascular survival. Cancer Metastasis Rev. 19, 75-81
41. Canbay, A., Kip, S. N., Kahraman, A., Gieseler, R. K., and Gerken, G. (2005) Apoptosis and fibrosis in non-alcoholic fatty liver disease. Turk. J. Gastroenterol. 16, 1-6
42. Gurtl, B., Kratky, D., Guelly, C., Zhang, L., Das, S. K., Tamilarasan, K. P., and Hoefler, G. (2009) Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy. Int. J. Exp. Pathol. 90, 338-346
43. Eltanani, M., Campbell, F., Kurisetty, V., Jin, D., and Rudland, P. (2006) The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 17, 463-474
44. Tzortzaki, E., Antoniou, K. M., Zervou, M. I., Lambiri, I., Tzanakis, N., Plataki, M., Maltezakis, G., Bouros, D., and Siafakas, N. M., (2007) Effects of antifibrotic agents on TGF-J31, CTGF and IFN-7 expression in patients with idiopathic pulmonary fibrosis. Respir. Med. 101, 1821-1829
45. Jang, Y, Arumugam, S., Gibran, N. S., and Isik, F. F. (1999) Role of av integrins and angiogenesis during wound repair. Wound Repair Regen. 7, 375-380
46. Wilgus, T. A., Ferreira, A. M., Oberyszyn, T. M., Bergdall, V. K., and Dipietro, L. A. (2008) Regulation of scar formation by vascular endothelial growth factor. Lab. Invest. 88, 579-590
47. Hernandez-Gea, V., and Friedman, S. L. (2011) Pathogenesis of liver fibrosis. Ann. Rev. Pathol. Mech. Dis. 6, 425-456
48. Povero, D., Busletta, C, Novo, E., Di Bonzo, L. V., Cannito, S., Paternostro, C, and Parola, M. (2010) Liver fibrosis: a dynamic and potentially reversible process. Histol. Histopathol. 25, 1075-1091
49. Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J., Benyon, C, and Iredale, J. P. (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J. Biol. Chem. 277, 11069-11076
50. Lemos, Q., and Andrade, Z. A. (2010) Angiogenesis and experimental hepatic fibrosis. Mem. Inst. Oswaldo Cruz 105, 611-614
51. Hannivoort, R. A., Hernandez-Gea, V., and Friedman, S. L. (2012) Genomics and proteomics in liver fibrosis and cirrhosis. F brogen T Repair 5, 1
52. Novo, E. (2005) Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 55, 1174-1182
53. Lee, J., Lee, K. S., Paik, Y, Nyun Park, Y, Han, K. H., Chon, C. Y, and Moon, Y. M. (2003) Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells. J. Hepatol. 39, 960-966
54. Maher, J. (2001) Interactions between hepatic stellate cells and the immune system. Semin. Liver. Dis. 21, 417-426
55. Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Moore-Morris, T., Scott, B., Tsukamoto, H., Evans, S. M., Dillmann, W., Glass, C. K., and Brenner, D. A. (2012) Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl. Acad. Sci. U. S. A. 109, 9448-9453
56. King, T., Jr., Pardo, A., and Selman, M. (2011) Idiopathic pulmonary fibrosis. Lancet. 378, 1949-1961
57. Meltzer, E., and Noble, P. W. (2008) Idiopathic pulmonary fibrosis. OrphanetJ. Rare Dis. 3, 8
58. Pardo, A. (2006) Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc. Am. Thorac. Soc. 3, 383-388
59. Razzaque, M., and Taguchi, T. (2003) Pulmonary fibrosis: cellular and molecular events. Pathol. Int. 53, 133-145
60. Hagimoto, N., Kuwano, K., Nomoto, Y, Kunitake, R., and Hara, N. (1997) Apoptosis and expression of Fas Flas ligand mRNA in bleomycin induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16, 91-101
61. Arenberg, D., Kunkelfl, S. A., Polverini, P. J., Morris, S. B., Glass, M. C, Taub, D. T., Iannettoni, M. D., Whyte, R. I., and Strieter, R. M. (1996) Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184, 981-992
62. Noble, P. W., and Homer, R. J. (2004) Idiopathic pulmonary fibrosis: new insights into pathogenesis. Clin. Chest Med. 25, 749-758, vii.
63. Hagimoto, N., Kuwano, K., Miyazaki, H., Kunitake, R., Kawasaki, M., Kaneko, Y., and Hara, N. (1997) Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17, 272-278
64. Kuwano, K., Kunitake, R., Maeyama, T., Hagimoto, N., Matsuba, T., Yoshimi, M., Inoshima, I., Yoshida, K., and Hara, N. (2001) Attenuation of bleomycin induced pneumopathy in mice by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L316-L325
65. Chen, F., Gong, L., Zhang, L., Wang, H., Wu, X., Xiao, Y., Cai, Y., Liu, L., Li, X., and Ren, J. (2006) Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats. Eur. J. Pharmacol. 536, 287-295
66. Farkas, L., Gauldie, J., Voelkel, N. F., Kolb, M. (2010) Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Am. J. Respir. Cell Mol. Biol. 45, 1-15
67. Renzoni, E. A. (2002) Interstitial vascularity in fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 167, 438-443
68. Cosgrove, G. P. (2004) Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am. J. Respir. Crit. Care Med. 170, 242-251
69. Ebina, M. (2004) Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 169, 1203-1208
70. De Fijter, J. (2010) Rejection and function and chronic allograft dysfunction. Kidney Int. 78, S38-S41
71. Schmauss, D., and Weis, M. (2008) Cardiac allograft vasculopathy: recent developments. Circulation. 117, 2131-2141
72. Taylor, D., Edwards, L. B., Boucek, M. M., Trulock, E. P., Keck, B. M., and Hertz, M. I. (2006) Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report-2006. J. Heart Lung Transplant. 25, 869-879
73. Denton, M., Davis, S. F., Baum, M. A., Melter, M., Exeni, A., Samsonov, D. V., Fang, J., Ganz, P., and Briscoe, D. M. (2000) The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection. Pediatr. Transplant. 4, 252-260
74. Huibers, M., De Jonge, N., Van Kuik, J., Koning, E., Dullens, H., Schipper, M., and De Weger, R. (2011) Intimal fibrosis in human cardiac allograft vasculopathy. Transpl. Immunol. 25, 124-132
75. Reinders, M. E. J. (2006) Angiogenesis and endothelial cell repair in renal disease and allograft rejection. (2006) J. Am. Soc. Nephrol. 17, 932-942
76. Reinders, M., Fang, J. C., Wong, W., Ganz, P., and Briscoe, D. M. (2003) Expression patterns of vascular endothelial growth factor in human cardiac allografts. Transplantation 76, 224-230
77. Wang, W. (2002) Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. Resistance to Fas ligand-induced apoptosis. J. Biol. Chem. 277, 21723-21729
78. Choy, J., Kerjner, A., Wong, B. W., McManus, B. M., and Granville, D. J. (2004) Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts. Am. J. Pathol. 165, 127-133
79. Shimizu, A., Yamada, K., Sachs, D. H., and Colvin, R. B. (2002) Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Kidney Int. 61, 1867-1879
80. Johnson, A., Francis, M., and Di Pietro, L. (2013) Differential apoptosis in mucosal and dermal wound healing. Adv. Wound Care In press